D. Thomas

发表

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

D. Vlahov, O. Laeyendecker, L. Wilson, 2000, JAMA.

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.

D. Vlahov, D. Hoover, D. Thomas, 1996, The Journal of infectious diseases.

Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)—Estimating HCV incidence in an urban emergency department population

Y. Hsieh, R. Rothman, D. Thomas, 2018, Journal of viral hepatitis.

Liver enzyme values in injection drug users with chronic hepatitis C.

D. Vlahov, D. Thomas, S. Strathdee, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

D. Thomas, L. Seeff, E. Mast, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

J. Ward, H. Razavi, D. Church, 2013, Journal of viral hepatitis.

Dynamics of SEN virus infection among injection drug users.

D. Vlahov, S. Ray, L. Wilson, 2001, The Journal of infectious diseases.

High viral load and mild liver injury in children with hemophilia compared with other children with chronic hepatitis C virus infection.

D. Thomas, J. Boitnott, E. Perlman, 1999, Journal of pediatric gastroenterology and nutrition.

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships.

T. Quinn, J. Zenilman, D. Thomas, 1995, The Journal of infectious diseases.

Public health clinic‐based hepatitis C testing and linkage to care in baltimore

C. Latkin, K. Ghanem, D. Thomas, 2016, Journal of viral hepatitis.

Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C‐DOT)

D. Thomas, S. Solomon, M. Sulkowski, 2018, Journal of viral hepatitis.

High prevalence of hepatitis C in Egyptian patients with chronic liver disease.

G. Strickland, D. Thomas, I. Waked, 1995, Gut.

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.

M. Alter, T. Quinn, D. Thomas, 1994, The Journal of infectious diseases.

Hip bone geometry in HIV/HCV-co-infected men and healthy controls

T. Travison, A. Araujo, A. Dobs, 2012, Osteoporosis International.

Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.

D. Vlahov, R. Purcell, A. Saah, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C. Epidemiologic quandaries.

D. Thomas, David L. Thomas, 2001, Clinics in liver disease.

Pathogen exposure misclassification can bias association signals in GWAS of infectious diseases when using population-based common controls

N. Chatterjee, C. Thio, D. Thomas, 2022, medRxiv.

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.

D. Vlahov, T. Sterling, N. Graham, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America.

T. Quinn, D. Thomas, T. Quinn, 1996, The American journal of medicine.

A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use

D. Vlahov, T. Inglesby, D. Thomas, 1999, Hepatology.

Genetic protection against HBV conferred by CCR5 Ä 32: evidence that CCR5 contributes to viral persistence

J. Goedert, C. Thio, M. Witt, 2006 .

Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection

S. Cosgrove, J. Silverberg, M. Betenbaugh, 2021, medRxiv.

Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

D. Vlahov, R. Garfein, D. Thomas, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Class II HLA alleles and hepatitis B virus persistence in African Americans.

M. Carrington, S. O’Brien, D. Vlahov, 1999, The Journal of infectious diseases.

In ﬂ ammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

R. Bollinger, D. Asmuth, D. Thomas, 2016 .

Hepatitis B viral DNA is methylated in liver tissues

M. Torbenson, D. Thomas, P. Vivekanandan, 2007, Journal of viral hepatitis.

Racial differences in HLA class II associations with hepatitis C virus outcomes.

J. Goedert, M. Carrington, S. O’Brien, 2001, The Journal of infectious diseases.

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.

D. Vlahov, D. Thomas, J. Astemborski, 1998, The Journal of infectious diseases.

Incident hepatitis C virus in women with human immunodeficiency virus infection.

J. Goedert, J. Feldman, N. Terrault, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda

D. Thomas, M. Kamya, S. Reynolds, 2010, International journal of STD & AIDS.

Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus

T. Quinn, D. Thomas, K. Gutekunst, 1996, Journal of clinical microbiology.

HTLV‐II and Bacterial Infections Among Injection Drug Users

D. Vlahov, L. Wilson, D. Thomas, 2000, Journal of acquired immune deficiency syndromes.

High seroprevalence of hepatitis C infection among risk groups in Egypt.

G. Strickland, D. Thomas, M. Mabrouk, 1994, The American journal of tropical medicine and hygiene.

Maternal Neutralizing Antibody and Transmission of HCV to her Infant

S. Ray, R. Hershow, D. Thomas, 2009 .

Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.

R. Elston, D. Thomas, Yuping Wu, 2008, Human immunology.

Genetic epidemiology of hepatitis C virus throughout egypt.

D L Thomas, J. Bukh, S. Ray, 2000, The Journal of infectious diseases.

Determinants of the quantity of hepatitis C virus RNA.

D. Vlahov, O. Laeyendecker, S. Ray, 2000, The Journal of infectious diseases.

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study.

Women, T. Quinn, L. Mofenson, 1998, The Journal of infectious diseases.

Human immunodeficiency virus and liver disease forum 2010: Conference proceedings

R. Chung, D. Thomas, David L. Thomas, 2011, Hepatology.

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

S. Ray, Brian E. Fisher, D. Thomas, 2012, Hepatology.

Hepatitis C epidemiology.

D. Thomas, David L. Thomas, 2000, Current topics in microbiology and immunology.

Vaccines to prevent viral hepatitis.

S. Lemon, D. Thomas, 1997, The New England journal of medicine.

Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence

M. Abdel-hamid, G. Strickland, M. Mohamed, 2000, Hepatology.

The epidemiology of hepatitis C in turkey

R. Mahley, T. Quinn, D. Thomas, 1994, Infection.

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

R. Chaisson, D. Thomas, M. Sulkowski, 2000, JAMA.

OCCULT HEPATITIS B INFECTION

M. Torbenson, D. Thomas, 2002 .

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India

M. Suresh Kumar, David L. Thomas, D. Thomas, 2016, PloS one.

Hepatitis C and human immunodeficiency virus infection

D. Thomas, 2002, Hepatology.

Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C

M. Saheed, Y. Hsieh, R. Rothman, 2022, Journal of viral hepatitis.

Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection

M. Torbenson, D. Thomas, E. Molmenti, 2004, Journal of viral hepatitis.

Long-Acting Treatments for Hepatitis B.

D. Thomas, M. Baum, J. Kiser, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B virus and sexual behavior in Rakai, Uganda

O. Laeyendecker, T. Quinn, M. Wawer, 2011, Journal of medical virology.

A hepatitis B virus (HBV) sequence variation graph improves sequence alignment and sample-specific consensus sequence construction for genetic analysis of HBV

C. Thio, D. Thomas, G. Wojcik, 2023, bioRxiv.

MICA and recovery from hepatitis C virus and hepatitis B virus infections

J. Goedert, M. Carrington, S. O’Brien, 2004, Genes and Immunity.

Association of hepatitis C virus infection with false-positive tests for syphilis.

T. Quinn, J. Zenilman, D. Hoover, 1994, The Journal of infectious diseases.

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland

D. Vlahov, D. Thomas, K. Nelson, 1997, Journal of clinical microbiology.

Seroreactivity to hepatitis E virus in areas where the disease is not endemic

D. Vlahov, R. Purcell, A. Saah, 1997, Journal of clinical microbiology.

Seroprevalence of Hepatitis E Virus in the UK Farming Population

D. Thomas, R. Salmon, E. Meader, 2010, Zoonoses and public health.

Peripheral blood count abnormalities among patients with hepatitis C in the United States

A. Zanella, P. Rebulla, D. Thomas, 2002, Hepatology.

Multicenter evaluation of hepatitis C RNA levels among female injection drug users.

J. Rich, D. Thomas, J. Astemborski, 2001, The Journal of infectious diseases.

Hepatitis C virus infection and incident type 2 diabetes

J. Pankow, M. Szklo, J. Coresh, 2003, Hepatology.

Hepatitis C pharmacogenetics: State of the art in 2010

K. Shianna, D. Goldstein, D. Booth, 2011, Hepatology.

Mother‐infant hepatitis C transmission: Second generation research

D. Thomas, 1999, Hepatology.

Epidemiology of hepatitis E virus infection in Turkey

R. Mahley, T. Quinn, D. Thomas, 1993, The Lancet.

Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study.

T. Quinn, L. Mofenson, R. Hershow, 1997, The Journal of infectious diseases.

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, medRxiv.

Severity and correlates of liver disease in hepatitis C virus–infected injection drug users

D. Vlahov, M. Torbenson, L. Wilson, 2002, Hepatology.

Persistence and clinical significance of hepatitis G virus infections in injecting drug users.

D. Vlahov, D. Thomas, J. Astemborski, 1997, The Journal of infectious diseases.

Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection

M. Torbenson, D. Thomas, J. Boitnott, 2008, Journal of Clinical Pathology.

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance

J. Goedert, S. O’Brien, C. Thio, 2005, Genes and Immunity.

An analysis of tumor necrosis factor α gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection

J. Goedert, S. O’Brien, D. Vlahov, 2004, Genes and Immunity.

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.

T. Quinn, D. Thomas, G. Kelen, 1993, Archives of internal medicine.

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

R. Garfein, R. Pollini, H. Hagan, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis

G. Lauer, A. Mangia, S. Khakoo, 2014, Genes and Immunity.

Hot tub legionellosis. Legionnaires' disease and Pontiac fever after a point-source exposure to Legionella pneumophila.

D L Thomas, D. Thomas, L. Mundy, 1993, Archives of internal medicine.

Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses

S. Klein, M. Betenbaugh, A. Pekosz, 2023, Journal of Immunological Methods.

Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing.

D. Vlahov, T. Quinn, P. Sánchez, 1997, The Journal of infectious diseases.

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

Noele P. Nelson, Jessica S. Rogers-Brown, C. Coffin, 2023, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Report on a single‐topic conference on “Chronic Viral Hepatitis–Strategies to Improve Effectiveness of Screening and Treatment”

W. Kim, J. Ward, A. Lok, 2012, Hepatology.

Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial

David M. Shade, A. Casadevall, B. Lau, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection

Richard D Moore, R. Chaisson, M. Torbenson, 2005, Hepatology.

Anti‐inflammatory cytokines, pro‐fibrogenic chemokines and persistence of acute HCV infection

D. Thomas, M. Chattergoon, W. Osburn, 2013, Journal of viral hepatitis.

Impact of Hepatitis C Treatment Uptake on Cirrhosis and Mortality in Persons Who Inject Drugs

D. Thomas, J. Astemborski, S. Mehta, 2022, Annals of Internal Medicine.

Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent

J. Goedert, C. Thio, R. Chung, 2014, Genes and Immunity.